Literature DB >> 28123738

Correlation of NEDD4-1 and PTEN expression with the invasive capacity of pituitary adenomas.

Jing Zhang1, Xin Li2, Yanyan Zhang1.   

Abstract

The aim of the present study was to correlate the expression of neural precursor cell expressed developmentally downregulated 4-1 (NEDD4-1) and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) with the invasive capacity of pituitary adenomas. A total of 50 pituitary adenoma tissues and 10 normal pituitary tissues were divided into the invasive group (26 cases), the non-invasive group (24 cases) and the normal group (10 cases). The expression of NEDD4-1 and PTEN was determined by immunohistochemistry. NEDD4-1 was revealed to be located in the nucleus and cytoplasm, whereas PTEN was only located in the cytoplasm. Furthermore, expression of NEDD4-1 was higher in pituitary adenomas compared with normal pituitary tissues (P<0.05), and higher in the invasive group compared with the non-invasive group, whereas the opposite trend was observed for PTEN. There was a strong negative correlation between NEDD4-1 and PTEN expression, indicating a dependency between the two and an association with invasiveness. In conclusion, NEDD4-1 may serve as a diagnostic and prognostic factor, and as a novel therapeutic target, in pituitary adenomas.

Entities:  

Keywords:  developmentally downregulated 4-1; immunohistochemistry; invasion; neural precursor cells; phosphatase and tensin homolog deleted on chromosome 10; pituitary adenomas

Year:  2016        PMID: 28123738      PMCID: PMC5244870          DOI: 10.3892/mco.2016.1092

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  25 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 2.  Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.

Authors:  Ting-Chao Chou
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivo.

Authors:  Lixin Wang; Bogdan Balas; Christine Y Christ-Roberts; Ryang Yeo Kim; Fresnida J Ramos; Chintan K Kikani; Cuiling Li; Chuxia Deng; Sara Reyna; Nicolas Musi; Lily Q Dong; Ralph A DeFronzo; Feng Liu
Journal:  Mol Cell Biol       Date:  2007-07-09       Impact factor: 4.272

4.  NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.

Authors:  Xinjiang Wang; Lloyd C Trotman; Theresa Koppie; Andrea Alimonti; Zhenbang Chen; Zhonghua Gao; Junru Wang; Hediye Erdjument-Bromage; Paul Tempst; Carlos Cordon-Cardo; Pier Paolo Pandolfi; Xuejun Jiang
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

5.  DJ-1, a novel regulator of the tumor suppressor PTEN.

Authors:  Raymond H Kim; Malte Peters; YingJu Jang; Wei Shi; Melania Pintilie; Graham C Fletcher; Carmela DeLuca; Jennifer Liepa; Lily Zhou; Bryan Snow; Richard C Binari; Armen S Manoukian; Mark R Bray; Fei-Fei Liu; Ming-Sound Tsao; Tak W Mak
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

6.  Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate.

Authors:  T F Franke; D R Kaplan; L C Cantley; A Toker
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

7.  E3 ligase Nedd4 promotes axon branching by downregulating PTEN.

Authors:  Jovana Drinjakovic; Hosung Jung; Douglas S Campbell; Laure Strochlic; Asha Dwivedy; Christine E Holt
Journal:  Neuron       Date:  2010-02-11       Impact factor: 17.173

8.  Phosphatase and tensin homologue and pituitary tumor-transforming gene in pituitary adenomas. Clinical-pathologic and immunohistochemical analysis.

Authors:  Martha Lilia Tena-Suck; Alma Ortiz-Plata; Horacio Astudillo de la Vega
Journal:  Ann Diagn Pathol       Date:  2008-06-12       Impact factor: 2.090

9.  Crucial role of the C-terminus of PTEN in antagonizing NEDD4-1-mediated PTEN ubiquitination and degradation.

Authors:  Xinjiang Wang; Yuji Shi; Junru Wang; Guochang Huang; Xuejun Jiang
Journal:  Biochem J       Date:  2008-09-01       Impact factor: 3.857

10.  Rak functions as a tumor suppressor by regulating PTEN protein stability and function.

Authors:  Eun-Kyoung Yim; Guang Peng; Hui Dai; Ruozhen Hu; Kaiyi Li; Yiling Lu; Gordon B Mills; Funda Meric-Bernstam; Bryan T Hennessy; Rolf J Craven; Shiaw-Yih Lin
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

View more
  1 in total

1.  Expression and methylation status of LAMA2 are associated with the invasiveness of nonfunctioning PitNET.

Authors:  Ruo-Qiang Wang; Yu-Long Lan; Jia-Cheng Lou; Yi-Zhu Lyu; Yu-Chao Hao; Qian-Fei Su; Bin-Bin Ma; Zhong-Bo Yuan; Zhi-Kuan Yu; Hong-Qiang Zhang; Dong-Sheng Wang; Ting-Zhun Zhu; Yan Ding; Ning Zhang; Bo Zhang
Journal:  Ther Adv Endocrinol Metab       Date:  2019-01-29       Impact factor: 3.565

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.